EC ever use among women of reproductive age: 3.2% (DHS 2005)
EC knowledge among women of reproductive age: 40.8% (DHS 2005)
Contraceptive Use: 77.4% (DHS 2005, ever use of any modern method among women of reproductive age)
Registered LNG-EC products:
- Emergyn - Available only with prescription
- Escinor 1.5 - Available only with prescription
- PostDay - Available only with prescription
- PostDay 1 - Available only with prescription
- Postinor 1* - Available only with prescription
- Postinor-2* - Available only with prescription
- Pregnon - Available only with prescription
- Previfem - Available only with prescription
- Tace - Available only with prescription
Registered UPA-EC products:
- ellaOne* - Available only with prescription
Products marked with * have been approved by a stringent regulatory authority, such as the WHO Prequalification Programme, the US Food and Drug Administration, the European Medicines Agency, or other.
Where at least one type of ECP is available: Pharmacies, IPPF-affiliated system
Age restrictions for accessing ECPs: No
Legal/regulatory documents in which EC is included: Essential Medicines List
Other relevant information: EC distributed via IPPF outlets (400,000 - 500,000 in 2012).